跳至主要内容
临床试验/EUCTR2012-002784-10-IT
EUCTR2012-002784-10-IT进行中(未招募)不适用

Clinical trial comparing contrast enhanced spectral digital mammography (CESM) and magnetic resonance imaging (MRI) to evaluate the effectiveness of neoadjuvant chemotherapy in patients with locally advanced breast cancer.

AZIENDA OSPEDALIERA ARCISPEDALE S. MARIA NUOVA0 个研究点开始时间: 2012年6月26日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • a.a diagnosis of breast cancer that will undergo neoadjuvant chemotherapy;
  • b.Over 18 years of age;
  • c.Agreement to undergo the study procedures and to sign the informed consent.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 0
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 20
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 30

排除标准

  • a.those with a known mutation of the gene BRCA;
  • b.those who cannot undergo MR examinations or for whom it is contraindicated;
  • c.those who are pregnant, demonstrated by blood tests;
  • d.those who have contraindications to the administration of iodine or gadolinium contrast agent (high creatinine value, renal insufficiency) or allergies to the contrast agent. Blood tests including creatinine levels will be performed every three weeks by the Oncology Department.

研究者

发起方
AZIENDA OSPEDALIERA ARCISPEDALE S. MARIA NUOVA

相似试验